PULSE BIOSCIENCES INC news, videos and press releases
For more news please use our advanced search feature.
PULSE BIOSCIENCES INC - More news...
PULSE BIOSCIENCES INC - More news...
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Pulse Biosciences, Inc. (NASDAQ: PLSE)
- Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
- Pulse Biosciences Schedules Second Quarter 2023 Financial Results Conference Call for August 10, 2023
- Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting
- Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
- Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
- Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer
- Pulse Biosciences Announces $65 Million Private Placement
- Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023
- Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
- Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023
- Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium
- Pulse Biosciences Reports Third Quarter 2022 Financial Results
- Pulse Biosciences Schedules Third Quarter 2022 Financial Results Conference Call for November 10, 2022
- Pulse Biosciences Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions
- Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia
- Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
- Pulse Biosciences Reports Second Quarter 2022 Financial Results
- Pulse Biosciences Receives FDA 510(k) Clearance of Expanded Energy Settings for use with the CellFX® System
- Pulse Biosciences Schedules Second Quarter 2022 Financial Results Conference Call for August 10, 2022
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering
- Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering
- Thinking about buying stock in Pulse Biosciences, Elevation Oncology, Borr Drilling, Sonoma Pharmaceuticals, or Shoals Technologies?
- INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm
- Pulse Biosciences, Inc. Announces Changes to its Rights Offering
- Pulse Biosciences Reports First Quarter 2022 Financial Results
- Pulse Biosciences, Inc. Announces Commencement of Rights Offering
- Pulse Biosciences Schedules First Quarter 2022 Financial Results Conference Call for May 11, 2022
- Pulse Biosciences to Present New Data on Nano-Pulse Stimulation Procedure for Sebaceous Hyperplasia and for Focal Epithelial Hyperplasia at 2022 American Society of Laser Medicine and Surgery Annual Conference
